Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
39 studies found for:    Open Studies | "Syncope"
Show Display Options
Rank Status Study
1 Recruiting Improving Syncope Risk Stratification in Older Adults
Condition: Syncope
Intervention:
2 Recruiting Diagnosis of Arrhythmias in Syncope by Pocket-ECG III® or Conventional Holter
Condition: Syncope
Intervention: Device: Pocket-ECG III system
3 Recruiting BAsel Syncope EvaLuation (BASEL IX) Study
Condition: Syncope
Intervention:
4 Recruiting Diagnostic Yield of an Ambulatory Patch Monitor in Unexplained Emergency Department Syncope: A Pilot Study (PATCH-ED)
Condition: Syncope
Interventions: Device: Novel ambulatory patch (ZIO® XT Patch);   Biological: BNP and hs-troponin I at 0 and 3 hours post ED attendance
5 Recruiting Ambulatory Post-Syncope Arrhythmia Protection Feasibility Study
Condition: Syncope
Intervention: Device: Short Term Wearable Defibrillator
6 Recruiting Benefit of Dual-chamber Pacing With Closed Loop Stimulation (CLS) in Tilt-induced Cardioinhibitory Reflex Syncope
Condition: Syncope
Interventions: Device: DDD-CLS;   Device: ODO
7 Recruiting Comparison Between Standard and Ultrasound Integrated Approach for Risk Stratification of Syncope in the Emergency Department
Condition: Syncope
Intervention:
8 Not yet recruiting Syncope Decision Aid for Emergency Care
Condition: Syncope
Intervention: Behavioral: SynDA
9 Recruiting Assessment of Midodrine in the Prevention of Vasovagal Syncope: The Prevention of Syncope Trial IV
Condition: Vasovagal Syncope
Interventions: Drug: midodrine hydrochloride;   Drug: matching placebo
10 Recruiting Syncope Prediction Study
Condition: Vasovagal Syncope
Intervention:
11 Recruiting A Proof of Principal Study of Atomoxetine for the Prevention of Vasovagal Syncope
Condition: Syncope, Vasovagal
Interventions: Drug: Atomoxetine;   Drug: Matching Placebo
12 Recruiting Assessment of Metoprolol in the Prevention of Vasovagal Syncope in Aging Subjects
Condition: Vasovagal Syncope
Interventions: Drug: Metoprolol;   Drug: Matching Placebo
13 Recruiting Prevention of Syncope Trial 6 - Atomoxetine in Vasovagal Syncope
Condition: Vasovagal Syncope
Interventions: Drug: Atomoxetine;   Drug: Placebo
14 Recruiting Efficacy of Transcatheter Ablation Using Anatomic Approach of Ganglionated Plexi Located in the Right Atrium to Prevent Neuromediated Cardioinhibitory Syncope
Condition: Neuromediated Cardioinhibitory Syncope
Intervention: Procedure: transcatheter ablation of ganglionated plexi in right atrium
15 Not yet recruiting The Iliac Arterio-venous Fistula for Treatment of Neurally Mediated Syncope Study
Condition: Neurally Mediated Syncope
Interventions: Device: ROX COUPLER;   Procedure: Right heart catheterisation and routine care
16 Not yet recruiting Remote Cardiac Monitoring of Higher-Risk Emergency Department Syncope Patients After Discharge
Conditions: Syncope;   Arrhythmia
Intervention: Device: Cardiophone
17 Recruiting Mechanisms of Vasovagal Syncope
Conditions: Vasovagal Syncope;   Postural Tachycardia Syndrome
Interventions: Drug: Phenylephrine;   Drug: L-Ng-monomethyl Arginine (L-NMMA)
18 Recruiting EEG Characteristics in Youth POTS and/or Syncope
Conditions: Syncope;   Postural Tachycardia Syndrome;   Orthostatic Intolerance
Intervention: Device: Abdominal and lower extremity compression
19 Recruiting Northera Improves Postural Tachycardia Syndrome (POTS) and Postural Vasovagal Syncope (VVS)
Conditions: Postural Tachycardia Syndrome (POTS);   Vasovagal Syncope (VVS);   Fainting
Interventions: Drug: Northera (Droxidopa);   Drug: Placebo
20 Recruiting Acarbose and Older Adults With Postprandial Hypotension
Conditions: Other Specified Hypotension;   Syncope
Interventions: Drug: Acarbose;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-39) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.